Epidermal growth factor (EGF) has been consid ered to be a candidate for neurotrophic factors on the basis of the results of several in vitro studies, However. the in vivo effect of EGF on ischemic neurons as well as its mechanism of action have not been fully understood. In the present in vivo study using a gerbil ischemia model, we examined the effects of EGF on ischemia-induced learning disability and hippocam pal CAl neuron damage. Cerebroventricular infusion of EGF (24 or 120 ng/d) for 7 days to gerbils starting 2 hours before or immediately after transient forebrain ischemia caused a signifi cant prolongation of response latency time in a passive avoid ance task in comparison with the response latency of vehicle treated ischemic animals. Subsequent histologic examinations showed that EGF effectively prevented delayed neuronal death of CA 1 neurons in the stratum pyramidale and preserved syn apses intact within the strata moleculare, radiatum, and oriens of the hippocampal CAl region. In situ detection of DNA Epidermal growth factor (EGF), a single-chain poly peptide composed of 53 amino acids, has been originally isolated from the submaxillary glands of male mouse. EGF is a well-known potent mitogen for a variety of cell types (Cohen, 1962; Carpenter and Cohen, 1979; Car penter and Wahl, 1990). The mitogenic activity is medi ated by the binding of EGF to a 170-kd cell surface receptor with intrinsic tyrosine kinase activity (Cohen et aI., 1980; Plowman et aI., 1990). Immunohistochemical Abbreviations used: EGF, epidermal growth factor; HEPES, N-(2hydroxyethyl) piperazine-N' -2-ethanesulfonic acid; MAP2, microtu bule-associated protein 2; PBS, phosphate-buffered saline; SIN-I, 3morpholinosydnonimine; TUNEL, terminal deoxynucleotidyltransfer ase-mediated 2' -deoxyuridine 5' triphosphate biotin nick end labeling. 349 fragmentation (TUNEL staining) revealed that ischemic ani mals infused with EGF contained fewer TUNEL-positive neu rons in the hippocampal CAl field than those infused with vehicle alone at the seventh day after ischemia. In primary hippocampal cultures, EGF (0.048 to 6.0 ng/mL) extended the survival of cultured neurons, facilitated neurite outgrowth, and prevented neuronal damage caused by the hydroxyl radical producing agent FeS04 and by the peroxynitrite-producing agent 3-morpholinosydnonimine in a dose-dependent manner. Moreover, EGF significantly attenuated FeS04-induced lipid peroxidation of cultured neurons. These findings suggest that EGF has a neuroprotective effect on ischemic hippocampal neurons in vivo possibly through inhibition of free radical neu rotoxicity and lipid peroxidation.
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In the first set of the present study, we used a gerbil model with transient forebrain ischemia and investigated whether EGF infusion into the cerebral ventricles pre vented the ischemia-induced reduction of response la tency time in a passive avoidance task and the ischemic neuronal death in the hippocampal CAl region. The sec ond set of experiments was designed to estimate with in situ detection of DNA fragmentation how many CAl neurons were in the course of degeneration after the 7day infusion of EGF or vehicle. The third set of experi ments was to see whether EGF, similar to other well known peptide growth factors (Mattson et aI., 1993; Zhang et aI., 1993; Mattson and Scheff, 1994) , could protect cultured neurons against oxidative injuries caused by the hydroxyl radical-producing agent FeS04 and by the peroxynitrite-producing agent 3morpholinosydnonimine (SIN-I) (Braughler et aI., 1986; Floyd, 1990; Stadtman and Oliver 1991) because hy droxyl radicals (Braughler et a1. 1986; Mattson et aI., 1993) and peroxynitrite (Bolanos et aI., 1997; Iadeco1a et aI., 1997; Samdani et aI., 1997) induced lethal damage to neurons during brain ischemia and reperfusion. Osmotic minipump implantation. The animals were anes thetized with 1.5% halothane in a 4:3 mixture of nitrous oxide and oxygen and placed in a stereotaxic apparatus. An osmotic minipump (Alza Corp., Palo Alto, CA) was implanted subcu taneously into the back of each animal, and a needle from the mini pump was placed in the left lateral ventricle at the point I.S mm anterior, 1.0 mm lateral, and 2.7 mm ventral to bregma as shown in the atlas of Thiessen and Yahr (1 977).
MATERIALS AND METHODS

In vivo ischemic experiments
Pre-ischemic infusion of EGF. EGF was purchased from Chemicon International Inc. (Temecula, CAl and dissolved in O.OS mollL phosphate-buffered saline (PBS) containing 0.1 % bovine serum albumin. EGF (24 or 120 ng/d) or vehi cle was infused for 7 days into the left lateral ventricles of normothermic gerbils exposed to 3-minute forebrain ischemia (n = 8 in each group). The molar concentrations of infused EGF were similar to those of the other growth factors so far examined in the same gerbil ischemia model (Wen et aI., 1995a,b; Matsuda et aI., 1996) . Six animals received insulin infusion in a dose of 120 ng/d to exclude the possibility of nonspecific effects of protein. Although insulin with a molecu lar weight similar to that of EGF has been shown to exhibit neurotrophic action at high concentrations (Zhu and Auer, 1993; Hamilton et aI., 1995) , we did not detect any neuropro tective action of insulin in vitro when the same molar concen trations of insulin as those of EGF were added to neuronal cultures (data not shown). Sham-operated animals received ve hicle infusion (n = 8). The infusion was started at 2 hours before an ischemic insult as described elsewhere (Sana et aI., 1994; Wen et aI., 1995a,b; Kotani et aI., 1996; Matsuda et aI., 1996) . 2 ng or lO ng EGF in 2 fLL of vehicle was injected into the left lateral ventricle through a Hamilton syringe (MS-25, Ito, Ja pan) immediately after 3-minute forebrain ischemia, and then EGF in a dose of 24 ng/d or 120 ng/d was continuously infused for 7 days into the cerebral ventricles as described above (n = 8 in each group). In control experiments, ischemic animals and sham-operated animals received vehicle infusion (n = 8 in each group).
Occlusion of the common carotid arteries. Occlusion of the common carotid arteries was performed as previously de scribed (Wen et aI., 1996) . Briefly, both common carotid ar teries were exposed through a ventral midline incision and separated carefully from the adjacent veins and nerves under inhalation anesthesia. Immediately after the termination of in halation anesthesia, the common carotid arteries were clamped for 3 minutes with aneurysm clips.
During forebrain ischemia, brain temperature has been shown to fall differently in individual animals, thereby affect ing the number of viable CAl neurons after ischemia (Mitani et aI., 1991) . To avoid the effect of unstable brain temperature on ischemic neuronal loss, we kept brain and rectal temperatures at 37.0 ± 0.2°C while clamping the common carotid arteries (Mi tani et aI., 1991; Sano et aI., 1994; Wen et aI., 1995a,b; Kotani et aI., 1996; Matsuda et aI., 1996; Wen et aI., 1996) . This enabled us to induce an invariable neuronal damage in the hippocampal CAl field even after such a brief ischemic insult (Sano et aI., 1994; Wen et aI., 1995a,b; Kotani et aI., 1996; Matsuda et aI., 1996) and to evaluate accurately the in vivo effect of EGF on delayed neuronal death.
Passive avoidance task. Seven days after forebrain isch emia, the gerbils were trained in a conventional step-down passive avoidance apparatus which was divided into a safe platform and a chamber with a stainless-steel grid floor (Araki et aI., 1986; Sano et aI., 1994; Wen et aI., 1995a, b; Kotani et aI., 1996; Matsuda et aI., 1996; Wen et aI., 1996) . Each animal was placed initially on the safe platform. When the gerbil stepped down onto the grid floor, it received a foot shock. Although the gerbil went repeatedly up and down between the platform and the grid, it eventually remained on the platform. This training session lasted 300 seconds. Twenty-four hours later, the gerbil was again placed on the safe platform while the shock generator was turned off, and the response latency, i.e., the time until it stepped down onto the grid floor, was mea sured. This test session also lasted 300 seconds. Each animal received only one training session and only one test session.
Histopathologic study of hippocampal CAl region. At I hour after the passive avoidance experiments, each animal was anesthetized with pentobarbital, and the osmotic minipump was disconnected from the needle placed in the lateral ventricle. Bromophenol blue was injected through the needle to ascertain the infusion of EGF, vehicle, or insulin into the cerebral ven tricles. Then the animals were perfused transcardially with 4% paraformaldehyde-2.5% glutaraldehyde in O.I-mol/L phos phate buffer (pH 7.4) for light and electron microscopy (Wen et aI., 1996) . Gerbils (approximately I in 16 animals) not showing diffusion of bromophenol blue were excluded from subsequent experiments. A brain region including the dorsal hippocampus from 0.5 to 1.5 mm posterior to bregma was removed and kept in the same fixative overnight at 4°C. Four serial coronal sec tions with 50 fLm in thickness at the level 1.0 to 1.2 mm posterior to bregma were cut with a microslicer (Dosaka EM, Japan) for electron microscopy. The remaining dorsal hippo campus was embedded in paraffin, and 5 fLm serial frontal sections were stained with 0.1 % cresyl violet. All neurons with intact morphologic appearance along I mm linear length of the CA I field in six serial coronal sections (1.20 to 1.23 mm pos terior to bregma) were counted. The mean number of neurons per section was calculated for each animal. For electron mi croscopy, the specimens were postfixed with I % osmium te-
Photomicrographs of the hippocampal CA 1 field of sham operated and ischemic gerbils. (A) sham-operated animal in fused with vehicle; (8) 3-minute ischemic animal infused with vehicle; C: 3-minute ischemic animal in which the infusion with 120 ng/d of EGF was started before the ischemia. Note that the infusion of EGF rescued a significant number of hippocampal CA 1 pyramidal neurons. Sections were stained with 0. 1 % cresyl violet. Bar = 100 ].Jm.
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troxide for 30 minutes, dehydrated with a graded series of ethanol, transferred to propylene oxide and embedded in epoxy resin. The strata moleculare, radiatum, pyramidale, and oriens of the CAl region were identified on semi thin sections stained with I % toluidine blue, and 70-nm ultrathin sections were made with a Reichert-Nissei ultramicrotome (Optische Werke, Austria) and mounted on single-slot (2 x 0.5 mm) grids that were coated with Formbar film. They were subjected to dual staining with uranyl acetate and lead citrate and observed in a transmission electron microscope.
In situ detection of DNA fragmentation (TUNEL stain ing). To analyze quantitatively the changes in the nuclear chro matin of the hippocampal CAl neurons as revealed by electron microscopy, we conducted TUNEL staining. Two additional paraffin sections from each animal in the EGF-and vehicle infused groups were processed for in situ detection of DNA fragmentation (TUNEL staining) to estimate the number of CA 1 neurons degenerating after the termination of EGF or vehicle infusion. Briefly, the sections were (I) deparaffinized in xylene and in a graded series of ethanol; (2) washed two times in 0.05 moIlL PBS for 10 minutes and then incubated with 20 f.lg/mL of proteinase K (Sigma) for 15 minutes; (3) rinsed with distilled water four times for 2 minutes each and quenched in 2.0% hydrogen peroxide for 10 minutes; (4) rinsed with PBS twice for 5 minutes each and incubated with equili bration buffer (Oncor, Inc.), and then incubated with a mixture of terminal deoxynucleotidyl transferase and reaction buffer containing digoxigenin-2' -deoxyuridine 5' triphosphate (On cor, Inc.) in a humidified chamber for 1 hour at 37°C; (5) immersed in wash buffer (Oncor, Inc.) for 10 minutes and washed with PBS three times for 5 minutes each; (6) incubated with anti-digoxigenin-peroxidase (Oncor, Inc.) for I hour at room temperature; and (7) rinsed with PBS three times for 5 minutes each and exposed to 0.05% diaminobenzidine and 0.02% hydrogen peroxide. All TUNEL-positive neurons along J mm linear length of the CA 1 field in the two serial coronal sections were counted and the mean number of positive neu rons was calculated in each animal.
In vitro culture experiments
Hippocampal neuron culture. The hippocampi of 17-day old rat embryos were aseptically dissected and hippocampal neurons were dissociated from the tissues as described else where (Kira et aI., 1995) . The dissociated cells were seeded on 24-well plastic plates (Coming, NY) coated with poly-L-Iysine (Sigma) at a density of 3 to 5 X 10 4 cells/cm 2 . The cells were cultured at 37°C in Dulbecco's modified Eagle's medium (0.1 % glucose; Nipro, Japan) supplemented with 10% fetal calf serum (Equitech-Bio, TX) under a humidified atmosphere with 5% CO2, On the second day of culture, the culture medium was replaced with serum-free Dulbecco's modified Eagle's medium containing 0 to 1 nmollL (or 0 to 6.0 ng/mL) EGF, 20 mmollL N-(2-hydroxyethyl)piperazine-N' -2-ethanesulfonic acid (HEPES), 0.45% glucose, 5 f.lg/mL pig insulin (Boehringer Mannheim), 5 f.lg/mL human transferrin (Boehringer Mannheim), 5 ng/mL sodium selenite (Boehringer-Mannheim), 25 nmollL progesterone (Sigma) and 0.1 % bovine serum albu min (Sigma). Then the cells were cultured for 3 days. On the third day of culture, freshly prepared 90 f.lmollL FeS04 or 20 f.lmollL SIN-l solution was added to the medium to introduce oxidative damage. The neurons exposed to FeS04 were main tained for 24 hours at 37°C and those exposed to SIN-J for 6 hours at 37°C (Braughler et aI., 1986; Floyd, 1990; Stadtman and Oliver 1991; Zhang et aI., 1993; Cheng and Mattson, 1995) . Neurons not exposed to FeS04 or SIN-l were also treated with the different concentrations of EGF. Then, the cells were fixed with the PHEM buffer (60 mmollL 1,4piperazinediethanesulfonic acid, 25 nmollL HEPES, 2 mmollL MgCI2 and I mmol/L ethylenedioxybis-N,N,N',N' -tetraacetic acid, pH 6.9) containing 4% paraformaldelhyde and 0.2% glu taraldelhyde for morphologic examination . used on 15 fLL of the sample and placed into each lane by using 6% polyacrylamide gel in the Laemm!i's buffer system (Laemmli, 1970) . The electrophoretic bands were transferred to nitrocellulose sheets (Towbin et al. 1979 ) and immunoblotted with a monoclonal antibody (Sternberger Monoclonals Inc., Baltimore) against microtubule-associated protein 2 (MAP2), which is known to be a specific neuronal marker. Anti-mouse immunoglobulin G coupled with alkaline phosphatase (Pro mega, Madison, WI) was used for the second immunoreaction.
The immunoreactive bands were visualized as described else where (Kira et aI., 1995) . Prestained molecular weight markers were purchased from Bio Rad (Richmond, CAl. For quantita tive evaluation, the immunoreactive bands of MAP2 were sub jected to densitometric analysis (Tanaka and Sobue, 1994) . Lipid peroxidation assays. Relative levels of lipid peroxi dation in cultured neurons were quantified by using 2thiobarbituric acid fixation and subsequent measurement of light absorbance at 535 nm (Buege and Aust, 1987) . Because this experiment needed a large number of neurons, we chose the cerebral cortex for material. The cortical neurons of 17day-old rat embryos were cultured at a density of 8.0 x 10 5 cells/cm 2 . Freshly prepared 10 fLmollL FeS04 solution was added to the medium, which was pretreated with 0 to 6.0 ng/mL EGF on the third day of culture, and the neurons were main tained for 2 hours at 37°C. Then the culture medium was re moved and 150 fLL of 1 % sodium dodecyl sulfate was added to each culture plate. The neurons were scraped off and collected into a I-mL tube, and 450 fLL of 0.375% thiobarbituric acid solution containing 0.015% dimethyl sulfoxide, 15% trichloro acetic acid, and 0.25 mollL of hydrochloric acid was added to the tube. After heating in a boiling water bath for 15 minutes, the homogenate was centrifuged at 10,000 x g for 5 minutes, and light absorbance at 535 nm was measured with a UV -120-02 spectrophotometer (Shimadzu, Japan).
Statistics
All in vivo experiments were performed blindly with respect to experimental group. The effects of EGF on response latency, CAl neuron density, and TUNEL-positive neuron number were evaluated by the two-tailed Mann-Whitney U test, which en abled us to compare the EGF-treated groups with the vehicle or insulin-treated ischemic group. Densitometric data of the immunoreactive bands and lipid peroxidation assays were evaluated by the one-way analysis of variance followed by post hoc test (Fisher's protected least significant difference). All data were represented as mean ± SD.
RESULTS
In vivo ischemic experiments
The mean response latency and CAl neuronal density of sham-operated animals with vehicle infusion were 240 ± 42 seconds and 24 1 ± 15 cells/mm, respectively, whereas those of 3-minute ischemic gerbils infused with vehicle alone were 123 ± 30 seconds and 133 ± 35 cells/ mm, respectively. There were significant differences in response latency (U = 0, P < .0 1) and CAl neuronal density (U = 0, P < .0 1) between the two groups (Fig.  lA, B) . In histologic sections, the CAl region of 3minute ischemic gerbils exhibited a marked decrease in viable neurons when compared with the CA I field of sham-operated animals ( Fig. 2A, B) .
The infusion of EGF in a dose of 120 ng/d into the lateral ventricle for 7 days, starting 2 hours before 3minute forebrain ischemia, caused a significant prolon gation in response latency time in the step-down passive avoidance task (EGF versus vehicle in ischemic gerbils: U = 12, P < .01; EGF versus insulin in ischemic gerbils: U = 9, P < .01) (Fig. lA) . Histologic examinations revealed that the treatment with 120 ng/d of EGF rescued many ischemic neurons that were destined to degenerate without EGF infusion (EGF versus vehicle in ischemic gerbils: U = 10, P < .01; EGF versus insulin in ischemic gerbils: U = 13, P < .01) (Figs. IB, 2C) . The lower dose of EGF (24 ng/d) was ineffective in the rescue of the ischemic neurons, although the mean response latency and CAl neuronal density were higher in EGF-infused ischemic animals than in vehicle/insulin-infused isch emic animals (Fig. lA, B) . EGF infusion in a dose of 120 ng/d for 7 days, starting just after forebrain ischemia, also caused a significant prolongation in response latency time in comparison with the response latency of vehicle-treated ischemic gerbils (EGF versus vehicle in ischemic animals: U = 6, P < .01) and rescued a significant number of ischemic CAl neurons (EGF versus vehicle in ischemic animals: U = 7, P < .01) (Fig. 3) . The lower dose of EGF (24 ng/d) was ineffective in the rescue of the ischemic neu rons (Fig. 3) .
In line with the results of the passive avoidance task and light microscopic observations, electron microscopy showed that the number of intact synapses within the stratum moleculare, stratum radiatum, and stratum oriens of the hippocampal CAl region was more in EGF-treated than in vehicle-treated ischemic gerbils (Fig. 4) . Under light microscopy, vehicle-treated hippocampal CAl neu rons surviving at the seventh day after transient forebrain ischemia seemed to be intact. However, a careful obser vation with an electron microscope revealed that a sig nificant number of neurons was possibly in the course of nuclear chromatin fragmentation and/or condensation to different degrees (Fig. 5A, B) ; the nuclei of vehicle treated ischemic neurons at early stages of degeneration had an irregular euchromatin with low electron density as compared with intact nuclear euchromatin (Fig. 5A ). On the other hand, most of surviving pyramidal neurons in the CA 1 field of EGF (120 ng/d)-treated gerbils re tained normal morphologic features even at the seventh day after forebrain ischemia (Fig. 5C) .
TUNEL staining revealed that many TUNEL-positive neurons were present in the hippocampal CAl field of 3-minute ischemic gerbils with vehicle infusion at the seventh day after ischemic insult, suggesting that irre versible neuronal degeneration was in progress at this period (Fig. 6A ). The 7-day infusion of EGF in a dose of 120 ng/d but not 24 ng/d starting either before or just after 3-minute ischemia not only prevented delayed neu ronal death in the hippocampal CA 1 field at the seventh day after ischemic insult but also reduced the number of TUNEL-positive neurons that were in the course of a more delayed degeneration (Fig. 6B, C) . The count of TUNEL-positive cells in the vehicle-infused ischemic gerbils indicated that without EGF treatment nearly half of the CA I neurons surviving at the seventh day after 3-minute ischemia would undergo a further degeneration within a few days (Fig. 7) . EGF treatment precluded the late onset of ischemia-induced neuronal death reminis cent of apoptosis (120 ng/d EGF versus vehicle infusion starting before ischemia: U = 0, P < .01; 120 ng/d EGF versus vehicle infusion starting after ischemia: U = 0, P < .01).
In vitro culture experiments
When EGF at concentrations of 0.04S to 6.0 ng/mL (O.OOS to 1 nmol/L) was added to the culture medium on the second day of culture, hippocampal neurons became more numerous than those without EGF treatment on the fifth day of culture (Fig. SA, B) . Moreover the neurons with EGF treatment gave rise to many processes (Fig.  SB) . As the hydroxyl radical-producing agent FeS04 was added to the culture medium, the processes of hippocam pal neurons were fragmented within 16 hours ( Fig. SC) and they were no longer visible within 24 hours. How ever, when the cultures were pretreated with EGF, the damage to hippocampal neurons as caused by FeS04 was apparently attenuated (Fig. SD) .
To quantify the trophic action of EGF on cultured hippocampal neurons, the neurons were solubilized, electrophoresed, and immunoblotted with a monoclonal antibody against MAP2. The control hippocampal neu rons not exposed to FeS04 exhibited a weak MAP2 band, and the MAP2 band increased in intensity in re sponse to EGF treatment (Fig. 9A) . The most effective concentration of EGF was 1.2 ng/mL (P < .01) (Fig. 9A) . In FeS04-exposed neurons, the MAP2 band was almost invisible without EGF treatment (Fig. 9B) . When EGF at concentrations of 0.04S to 6.0 ng/mL was added to the culture medium beforehand, the MAP2 band signifi cantly increased in intensity (Fig. 9B ), suggesting that FeS04-induced neuron death was prevented by EGF. Pretreatment with EGF at concentrations of 0.048 to 6.0 ng/mL also protected hippocampal neurons against SIN I-induced damage in a dose-dependent manner (Fig. 10) . Similar results were obtained when cortical neurons were used instead of hippocampal neurons in the above culture studies, except that the concentration of FeS04 inducing oxidative injury to cortical neurons was 10 [LmollL (data not shown).
For the assays of lipid peroxidation, we used cortical neurons instead of hippocampal neurons because of the need of more neurons. The exposure of cortical neurons J Cereh Blood Flow Metah, Vol. 18, No. 4, 1991! to 10 [LmoIIL FeS04 for 2 hours resulted in a significant increase in thiobarbituric acid-reactive substances (Fig.  11) due to the induction of lipid peroxidation. Preincu bation with EGF significantly attenuated the FeS04induced lipid peroxidation in a dose-dependent manner (Fig. 11 ).
DISCUSSION
The present in vivo study showed that the continuous infusion of EGF into the lateral ventricle starting either before or just after forebrain ischemia prolonged re sponse latency time in the passive avoidance task. The 
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FIG. 9. MAP2-immunoblot analysis of EGF-treated hippocampal neurons not exposed to (A) or exposed to FeS04 (8). Samples cultured with 0 to 6.0 ng/mL of EGF were immunoblotted with a monoclonal antibody against MAP2. In control samples, a MAP2-positive band was observed (a in A). The intensity of MAP2-immunoreactive bands increased in cultures treated with 0.048-6.0 ng/mL of EGF (c-f in A). The cultured sample with FeS04 treatment but without EGF pretreatment showed an extremely weak immunoreactive band (a in B).
In samples treated with 0.048-6.0 ng/mL of EGF and then with FeS04, the intensity of MAP2-immunoreactive bands also increased even if FeS04 existed in the cultures (c-f in B). The densitometric analysis of MAP2-immunoreactive bands showed that EGF enhanced the survival and possibly the neurite extension of hippocampal neurons not exposed to FeS04 (A) and protected the neurons against FeS04-induced oxidative injuries (B) in a dose-dependent manner. The data were obtained from four separate cultures and expressed as percentage of the corresponding control culture. Each column indicates mean ± SO .• P < 0,05, •• P < 0.01; ••• P < 0.001, significantly different from the corresponding control value (tested with one-way analysis of variance followed by Fisher's PLSO).
improvement in behavioral score correlated well with the results of subsequent histologic examinations showing the suppression by EGF of delayed neuronal death in the hippocampal CA l field. These results suggest that EGF can act as a neuroprotective agent in brain ischemia.
Although EGF has been known as a neuroprotective agent in vitro, this is the first report showing that EGF can protect hippocampal neurons against ischemia induced damage in vivo. In vitro experimental results, however, do not always reflect in vivo events in the isch emic brain. In fact, all cytokines or growth factors with neurotrophic actions in vitro do not necessarily exhibit neuroprotective effects on ischemic brain in vivo. For example, granulocyte/macrophage colony-stimulating factor has been reported to have a neuroprotective activ ity in vitro (Kamegai et al. 1990 ), whereas in the isch emic gerbil model we did not obtain results in support of the in vitro experiments (Peng et al. unpublished obser vations, August, 1996) . Perhaps, the amount of growth factors or cytokines that reach the hippocampus after their infusion into the cerebral ventricles varies among growth factors/cytokines, and endogenous growth fac tors/cytokines as well as their receptors may respond differentially to ischemic insult in the brain. Accord-ingly, the in vivo action mechanisms of exogenous growth factors/cytokines are rather difficult to determine at this moment. EGF is produced in neuronal cells including hippo campal neurons (Schaudies, et al. 1989; Birecree, et al. 1991) . EGF receptor is also expressed in neurons within a variety of brain regions including the hippocampus (Werner et al. 1988; Birecree et al. 1991) . It is not clear whether these observations imply that EGF acts on neu ronal cells in an autocrine fashion. Production of EGF itself appears to be rather poor in amount within the hippocampal formation, but EGF receptor is highly ex pressed in the hippocampus (Birecree et al. 1991) . Fur ther, EGF is present in the CSF (Hirata et al. 1982) . Therefore, it is plausible that EGF is produced by certain populations of neurons and plays a neuroprotective role in the ischemic brain in a paracrine manner. We specu late that under normal conditions the activities of the hippocampal CA 1 pyramidal neurons are maintained, at least in part, by EGF derived from other neurons, but in the ischemic brain the supply of EGF becomes insuffi cient. If this is true, the infusion of EGF may be experi mentally a favorable medication to attenuate the isch emia-induced neuronal damage. Indeed, as shown in the MAP2-immunoblot analysis of EGF·treated hippocam pal neurons exposed to SIN-1. Samples cultured with 0 to 6.0 ng/mL of EGF were immunoblotted with a monoclonal antibody against MAP2. In control samples, an intense MAP2·positive band was observed (a). The cultured sample with SIN-1 treat ment but without EGF pretreatment showed a weak immunore active band (b). In samples treated with 0.048-6.0 ng/mL EGF and then with SIN-1, the intensity of MAP immunoreactive bands increased (d-g). The densitometric analysis of MAP2immunoreactive bands showed that EGF protected the neurons against SIN-Hnduced oxidative injuries in a dose-dependent manner. The data were obtained from four separate cultures and expressed as percentage of the control culture which was not exposed to SIN-1. Each column indicates mean ± SD. * P < 0.05, ** P < 0.01, significantly different from the SIN-1-treated control value (tested with one·way analysis of variance followed by Fish er's PLSD).
present study, exogenous EGF infusion into the cerebral ventricles of ischemic gerbils significantly rescued CA I neurons from delayed neuronal death.
In the conventional 5-minute forebrain ischemia tech nique for which brain temperature is not maintained at 37.0 ± 0.2°C during ischemia, TUNEL-positive CAl neurons have been shown to peak at the fourth day after ischemic insult, and only few ones are visible at the seventh day after ischemia possibly because of the so called delayed death of almost all CA 1 neurons (Nitatori et aI., 1995) . In contrast, the normothermic gerbils with 3-minute forebrain ischemia exhibited many TUNEL positive neurons in the hippocampal CAl field even at the seventh day after ischemia. This finding suggests that the hippocampal CAl neurons after 3-minute ischemia undergoes a progressive degeneration at a slower rate than those after 5-minute ischemia. Thus, the present animal model with an episode of 3-minute ischemia has a wider therapeutic window than the conventional 5-minute ischemia model and may be useful for the screen ing of neuroprotective agents. Indeed, EGF treatment, starting either before or after 3-minute ischemia, reduced dramatically the number of TUNEL-positive neurons in comparison with those of 3-minute ischemic gerbils with vehicle infusion. This indicates that the slowly progres sive degeneration as observed in the vehicle-treated ger bils at the seventh day after 3-minute ischemia is mark edly inhibited by EGF even after the termination of its infusion. In situ detection of DNA fragmentation (TUNEL-staining) appears to be a reliable tool to assess the effects of neuroprotective agents on the late degen eration of hippocampal CAl neurons in 3-minute isch emic gerbils. We speculate that a brief ischemic insult similar to 3-minute ischemia in gerbils is occasionally loaded to the human brain leading to sustained damage of the ischemic focus. If this is the case, continuous treatment with peptide growth factors (Sano et aI., 1994; Wen et aI., 1995a,b; Kotani et aI., 1996; Matsuda et aI., 1996) or nonpeptide neuroprotective agents (Wen et aI., 1996; Lim et aI., 1997; Matsuda et aI., 1997) may be needed to lessen slowly progressive ischemic neuronal damage in patients with mild or brief brain ischemia.
The mechanism(s) by which EGF prevents delayed neuronal death in vivo is not clear at present, but the ability of EGF to protect oxidative injuries and to sup press accumulation of lipid peroxides may account for the action mechanism of EGF in part, as suggested by the 300 Dnot exposed to FeS04 exposed to FeS04 Cultures were pretreated with 0 to 6.0 ng/mL of EGF and then exposed to 10 IJM FeS04 for 2 hours. Neurons were then fixed with TBA and light absorbance at 535 nm was measured. The data were obtained from 5 separate cultures and expressed as percentage of the control culture which was not exposed to FeS04. * P< 0.05, ** P< 0.01, *** P< 0.001, significantly different from the FeS04-treated control value (tested with one-way analy sis of variance followed by Fisher's PLSD).
present in vitro study. Free radicals and lipid peroxides overproduced after brain ischemia and reperfusion are responsible for brain edema and neuronal damage (Flamm et aI., 1978; Siesjo, 1981; Chan et aI., 1984; Kogure et aI., 1985; Bolanos et aI., 1997; Iadecola et al., 1997; Samdani et aI., 1997) . Lipid peroxides in the hip pocampal CA 1 region are increased after cerebral isch emia in the rat (Arai et aI., 1987; Bromont et aI., 1989) . Hara et ai. (1990) have reported that post-ischemic ad ministration of a-tocopherol, a free radical scavenger, prevents delayed neuronal death in the ischemic hippo campal CA L region. Thus, inhibition of free radical gen eration and/or lipid peroxidation is likely to prevent the occurrence of brain edema and neuronal damage. In the present study, pretreatment of neurons in cultures with EGF successfully prevented neuronal death and lipid peroxidation induced by FeS04 which has been used to generate hydroxyl radicals in culture (Zhang et ai. 1993; Cheng et ai. 1995) . Because the simultaneous addition of EGF and FeS04 into the culture medium did not attenu ate FeS04 neurotoxicity (data not shown), EGF itself dose not appear to act as a radical scavenger. In addition, pretreatment with EGF significantly protected hippo campal neurons against oxidative damage caused by SIN-l which is known to generate superoxide radicals and nitric oxide causing to the formation of peroxynitrite (Groot et aI., 1993) . Furthermore, the present in vitro results on the dose-dependency of EGF showed that EGF displayed its neurotrophic and neuroprotective effects on hippocampal neurons at concentrations of 0.008 to I nmollL. This effective concentration of EGF is in the range of the Kd value (0.02 to 0.05 nmollL) of EGF receptor. Therefore, it is likely that EGF acts through binding to its receptor on neuronal cell surface. Basic fibroblast growth factor, nerve growth factor, and brain-derived neurotrophic factor, which are all well known neurotrophic factors, reduce lipid peroxidation induced by glutamate exposure (Mattson et aI., 1995) . It has also been shown that the three neurotropic factors enhance more or less the activities of antioxidant en zymes such as superoxide dismutase, glutathione peroxi dase, and catalase (Mattson et aI., 1995) . Because recep tors for EGF, basic fibroblast growth factor, brain derived neurotrophic factor, and nerve growth factor use similar transduction pathways via tyrosine phosphoryla tion (Schlesinger and Ulrich, 1992) , EGF may rescue ischemic neurons by enhancing the activities of the an tioxidant enzymes. On the other hand, Kinoshita et al. (1990) reported that EGF rescued neurons from anoxic injury in vitro. Under the anoxic environment, the en hancement of antioxidant enzymes by EGF may not be responsible for the neuroprotective effect. The antianoxic action of EGF may play a significant role in rescuing ischemic neurons together with the anti-oxidant activity.
